Ocuco announces the company’s rebrand to a more contemporary, refined version of its original brand. It is an evolution that reflects the direction of the whole company....
While for many, myopia is an optically corrected inconvenience, for an ever-increasing minority, myopia is a factor leading to more severe vision disorders and visual impairment in mid to later life. Myopia is a recognised growing health issue in East Asia, where large-scale measurement...
The COVID-19 pandemic has propelled the omnichannel approach to the forefront of the optical industry, moving from a 'nice-to-have' to a business need. ...
Up to 50% of people in the Northern Hemisphere suffer from Dry Eye Disease (DED), with or without symptoms. These impressive numbers, published in the TFOS DEWS II Report Executive Summary, can be even more substantial. In some populations, DED prevalence was higher and more...
Ransomware is to data as Glaucoma is to Optometry. One steals away data as the other steals away sight. Ransomware, a type of malware that threatens to perpetually block access to a victim’s data unless a ransom is paid, affects everything from small businesses right...
As a result of the continuously evolving COVID-19 virus, recent reports from the World Health Organization (WHO), national and regional guidelines from public health officials and Ocuco’s concern for the health and safety of our customers and employees, the Innovations Lab management team took the...
Ocuco has been named as one of Ireland’s Best Managed companies in the Deloitte Best Managed Companies Awards programme....
Ocuco has appointed Dr. Ian Lane, OD, FAAO to the position of US Product Director and Chief Medical Officer, focusing on Ocuco’s flagship product, Acuitas....
Ocuco are pleased to announce that our new websites for Swedish and Norwegian customers are now live...
